#CvPrev
LightNews LightNews
jaccjournals.bsky.social
Heart and liver, one metabolic disease. MASLD fuels cardiovascular risk through inflammation, insulin resistance and fat toxicity. Time for cardiologists to lead in diagnosis and prevention.

More in the new issue of #JACC: https://bit.ly/3XiYxrB

#cvMetabolic #cvPrev #CardioSky
November 11, 2025 at 5:36 PM
accintouch.bsky.social
#AHA25: ACC Vice President Roxana Mehran, MD, FACC, shares insights on groundbreaking cardiometabolic therapeutic trials, including highlights from the VESALIUS-CV study.

Get the full details here: https://bit.ly/4oBNohQ

#cvPrev #cvLipids #ACCAnywhere #CardioSky #MedSky
November 8, 2025 at 7:51 PM
escardio.bsky.social
#AHA25

Discover the North American collection, specially curated by #EJPC to showcase regional cutting-edge science shaping the future of #cvprev 👉 https://ow.ly/85Vn50XoaGB
November 7, 2025 at 1:01 PM
accintouch.bsky.social
High-dose inactivated influenza vaccine demonstrated significantly greater effectiveness in ↘️ severe outcomes & hospitalizations compared w/ standard-dose inactivated influenza vaccine, based on findings from the FLUNITY-HD pooled analysis.

🔗 https://bit.ly/43JhaIK #cvPrev #CardioSky #MedSky
FLUNITY-HD: High-Dose Flu Vaccine Outperforms Standard Dose in Reducing Hospitalizations - American College of Cardiology
bit.ly
October 30, 2025 at 7:15 PM
accintouch.bsky.social
🆕 #JACC Focus Issue: High BP Guideline Spotlight dives into the implementation failures that have led to #hypertension going undiagnosed, untreated & inadequately controlled in the U.S. & charts a path forward.

Read more: https://bit.ly/4nCDlry #cvPrev #CardioSky #MedSky
October 28, 2025 at 3:35 PM
accintouch.bsky.social
Preexisting hyperlipidemia in pregnancy is associated w/ heightened risk of obstetric complications & early CV events within five years postpartum, according to research presented at #ACCCardioOB Essentials conference.

Read more: https://bit.ly/3L0l2i5 #CardioObstetrics #cvPrev #CardioSky #MedSky
October 18, 2025 at 8:35 PM
accintouch.bsky.social
👀Keep your eyes on prevention.

#NCDAcademy’s new course connects the dots between #NCDs and eye health, covering cataract, glaucoma, macular degeneration, and more. 👁️

📘 Start learning: https://bit.ly/3INnSXb

@worldheart.org #cvPrev
October 13, 2025 at 6:55 PM
accintouch.bsky.social
🚬 Does exposure to environmental triggers increase tobacco use? According to a study by Benjamin Muzekari, MA, et al., smoking and craving increased in daily cigarette smokers exposed to retail tobacco outlets.

Explore the findings: https://bit.ly/4q1xwGr

#cvPrev #CardioSky
#PublicHealth #ACCPrev
October 9, 2025 at 9:08 PM
accintouch.bsky.social
🔑 New Scientific Statement: Inflammation plays a key role in #ASCVD.

Fred Kusumoto, MD, FACC, highlights recommendations for screening, prevention & treatment.

Watch the video 🎥 and read more here: https://bit.ly/46VIeoX

#JACC #cvPrev @JACCJournals
October 7, 2025 at 6:58 PM
accintouch.bsky.social
#ACCPresident @chriskramermd.bsky.social wraps up Day 2 at #ACCMidEast, reflecting on a day filled with insights, innovation, and global collaboration 🌎 from advances in multimodality imaging to key discussions in #cvPrev, and more.

#ACCIntl #CardioSky #MedSky
October 4, 2025 at 2:27 PM
accintouch.bsky.social
#ACCMidEast: New immigrants to the U.S. have a lower prevalence of #CVD risk factors than individuals born in the U.S., but these risk factors increase the longer they live in the U.S., a so-called "healthy immigrant effect".

Learn more: https://bit.ly/46N14Pa

#ACCIntl #cvPrev #CardioSky #MedSky
October 4, 2025 at 4:05 AM
federicafogacci.bsky.social
Happening Today – Don’t Miss It!
Join the @eassociety.bsky.social webinar at 17:00 CET to explore the latest Lp(a) guidelines with Dr. Koskinas and Prof. @LaleTokgozoglu. Bring your questions and join the live Q&A—we can’t wait to connect with you online 💫
Rego: eas.to/WebSep29Reg
#EASSoMe #CvPrev
Welcome! You are invited to join a webinar: EAS/ESC Guidelines: Lipoprotein(a) – guideline updates and clinical case. After registering, you will receive a confirmation email about joining the webinar...
Join us for an insightful webinar exploring the latest Lipoprotein(a)-related guideline recommendations. The session will feature a 20-minute overview presentation by Dr Konstantinos Koskinas, followe...
eas.to
September 29, 2025 at 8:19 AM
federicafogacci.bsky.social
Feeling honored to be recognized for the 3rd consecutive year on Stanford University and Elsevier’s Top 2% Scientists list. #Grateful to my incredible colleagues and mentors — thank you for your support as we keep pushing boundaries and growing together @unibo.it @eassociety.bsky.social #CvPrev
September 28, 2025 at 8:28 AM
accintouch.bsky.social
This morning, Dr. Valentin Fuster, MD, PhD, MACC, was joined by Dr. David Kershenobich Stalnikowitz, MD, PhD, Mexico’s Minister of Health, for an exclusive live conversation on the future of #cvPrev. 👇

#ACCIntl #ACCLATAM #CardioSky #MedSky
September 19, 2025 at 5:55 PM
accintouch.bsky.social
Valentin Fuster, MD, PhD, MACC and esteemed panel discussing the importance of #cvPrev at #ACCLATAM 2025. “Preventive cardiology must evolve from individual interventions to systemic change."

More from a recent #CardiologyMag article 👉 https://bit.ly/4pv04I5

#ACCIntl #CardioSky #MedSky
September 19, 2025 at 2:52 PM
accintouch.bsky.social
🆕 research presented at #ESCCongress exploring reconditioned pacemakers use in low- & middle-income countries & a home-based model of #hypertension care in South Africa signals promising advancements for global heart health.

Learn more: https://bit.ly/4g17ONL
#ACCIntl #cvPrev
September 1, 2025 at 3:48 PM
accintouch.bsky.social
Results from DANCAVAS 2 and ABC-AF trials presented at #ESCCongress explore personalized treatments for #cvPrev with mixed results. Read the details: https://bit.ly/4p7LsOL
August 31, 2025 at 7:56 AM
accintouch.bsky.social
📺 It's time for another #ACCAnywhere TV From #ESCCongress Daily Wrap Up! ACC Clinical Content Editor-in-Chief Dr. Fred Kusumoto discusses CVD prevention 🔥 trials of the day with ACC's Prevention of CVD Member Section Chair Dr. @Eugenia Gianos. #cvPrev #ACCPrev https://bit.ly/4mE7bfi
August 30, 2025 at 4:46 PM
escardio.bsky.social
NEW Focused update of the 2019 #ESCGuidelines on #dyslipidaemias : bit.ly/4fVz6F4

#lipids #riskfactors #cvprev
August 29, 2025 at 7:30 AM
jaccjournals.bsky.social
📢 New AHA/ACC statement reviews the rationale for using the Predicting Risk of #CVD Events equations, the ≥7.5% 10-yr risk threshold, & population-level impact.

Get the details in #JACC: https://bit.ly/3HJhWxV

#CardioSky #Hypertension #cvPrev @accintouch.bsky.social
August 28, 2025 at 6:31 PM
accintouch.bsky.social
🆕 ACC Concise Clinical Guidance Consolidates Recommendations on Immunization as Part of CV Care

Primary vaccine takeaways include:
✅ Influenza
✅ Pneumococcal
✅ #COVID19
✅ RSV
✅ Shingles

📖 Read the journal scan for more: https://bit.ly/41nCanx

#cvPrev #CardioSky #MedSky
August 26, 2025 at 3:55 PM
jaccjournals.bsky.social
The ACC’s new Clinical Guidance urges immunizations for adults with heart disease, protecting against the #flu, #COVID19, #RSV, and other vaccines shown to benefit heart health. www.jacc.org/doi/10.1016/...

#JACC #cvPrev #CVD #CardioSky #MedSky
August 26, 2025 at 2:39 PM
jaccjournals.bsky.social
Pop-up screening for #ASCVD risk held at community pharmacies & large-scale sporting events can identify people w/ uncontrolled CV risk factors, according to a study published in #JACC & simultaneously presented at #CSANZ2025. www.jacc.org/doi/10.1016/... #cvPrev #CardioSky
Pop-Up Cardiovascular Screening Within Community Pharmacies and an International Sporting Event:
www.jacc.org
August 15, 2025 at 1:20 PM
cvprevention.medsky.social
I'm thrilled to share our recent publication challenging exercise #BP post #SCAD! 🏃‍♀️Time to Re-Evaluate Blood Pressure Recommendations for Exercise Testing in SCAD? A Case Series. www.cjcopen.ca/article/S258... 🫀 #CVPrev #CVRehab #HerHeartMatters @kiteuhn.bsky.social @cjcjournals.bsky.social
August 6, 2025 at 10:20 PM
federicafogacci.bsky.social
Super excited to be selected for the first IAS Inflammation Academy 🌟
Looking forward to learning, sharing ideas, and being inspired by amazing mentors and peers #CvPrev
#EASSoMe @eassociety.bsky.social
🔗https://athero.org/ias-inflammation-academy/
July 24, 2025 at 6:05 AM